Published in Arch Intern Med on March 08, 1999
Heart disease and stroke statistics--2012 update: a report from the American Heart Association. Circulation (2011) 31.98
Heart disease and stroke statistics--2013 update: a report from the American Heart Association. Circulation (2012) 30.79
Heart disease and stroke statistics--2011 update: a report from the American Heart Association. Circulation (2010) 30.07
Heart disease and stroke statistics--2014 update: a report from the American Heart Association. Circulation (2013) 28.02
British Thoracic Society guidelines for the management of suspected acute pulmonary embolism. Thorax (2003) 5.83
The epidemiology of venous thromboembolism in the community. Arterioscler Thromb Vasc Biol (2008) 3.50
Heart Disease and Stroke Statistics-2017 Update: A Report From the American Heart Association. Circulation (2017) 2.76
Derivation and validation of a prognostic model for pulmonary embolism. Am J Respir Crit Care Med (2005) 2.51
Assessment of postoperative venous thromboembolism risk in plastic surgery patients using the 2005 and 2010 Caprini Risk score. Plast Reconstr Surg (2012) 2.25
Venous thromboprophylaxis in UK medical inpatients. J R Soc Med (2005) 2.14
Risk of venous thromboembolism in patients with rheumatoid arthritis: a systematic review and meta-analysis. Clin Rheumatol (2014) 2.08
Epidemiology and risk factors for venous thrombosis. Semin Hematol (2007) 1.90
Deep vein thrombosis after monoclonal gammopathy of undetermined significance and multiple myeloma. Blood (2008) 1.78
Venous thromboembolism-related mortality and morbidity in King Fahd General Hospital, Jeddah, Kingdom of Saudi Arabia. Ann Thorac Med (2011) 1.56
Diagnosis of pulmonary embolism. CMAJ (2003) 1.31
A genome-wide association study of venous thromboembolism identifies risk variants in chromosomes 1q24.2 and 9q. J Thromb Haemost (2012) 1.23
Correlates and consequences of venous thromboembolism: The Iowa Women's Health Study. Am J Public Health (2009) 1.18
Epidemiology of venous thromboembolism. Nat Rev Cardiol (2015) 1.07
Clinical presentation of acute pulmonary embolism: survey of 800 cases. PLoS One (2012) 1.04
Review of the evidence on diagnosis of deep venous thrombosis and pulmonary embolism. Ann Fam Med (2007) 1.04
Long-term survival in a large cohort of patients with venous thrombosis: incidence and predictors. PLoS Med (2012) 1.03
The epidemiology of venous thromboembolism. J Thromb Thrombolysis (2016) 1.00
The prothrombotic phenotypes in familial protein C deficiency are differentiated by computational modeling of thrombin generation. PLoS One (2012) 0.97
Risk factors and underlying mechanisms for venous stasis syndrome: a population-based case-control study. Vasc Med (2009) 0.96
Mechanical breakdown and thrombolysis in subacute massive pulmonary embolism: A prospective trial. World J Cardiol (2013) 0.94
Predictors of venous thromboembolism recurrence and bleeding among active cancer patients: a population-based cohort study. Blood (2014) 0.94
Risk of site-specific cancer in incident venous thromboembolism: a population-based study. Thromb Res (2014) 0.94
In vivo magnetization transfer and diffusion-weighted magnetic resonance imaging detects thrombus composition in a mouse model of deep vein thrombosis. Circ Cardiovasc Imaging (2013) 0.93
Values of the Wells and revised Geneva scores combined with D-dimer in diagnosing elderly pulmonary embolism patients. Chin Med J (Engl) (2015) 0.93
Fibrin-targeted magnetic resonance imaging allows in vivo quantification of thrombus fibrin content and identifies thrombi amenable for thrombolysis. Arterioscler Thromb Vasc Biol (2014) 0.92
Risk of myocardial infarction and overall mortality in survivors of venous thromboembolism. Thromb J (2008) 0.91
Evolving use of new oral anticoagulants for treatment of venous thromboembolism. Blood (2014) 0.90
Pulmonary embolism in the elderly: a review on clinical, instrumental and laboratory presentation. Vasc Health Risk Manag (2008) 0.89
Oral thromboprophylaxis following total hip or knee replacement: review and multicentre experience with dabigatran etexilate. Open Orthop J (2011) 0.85
Long-term activation of the pro-coagulant response after neoadjuvant chemoradiation and major cancer surgery. Br J Cancer (2009) 0.84
Preoperative factors affecting length of stay after elective anterior cervical discectomy and fusion with and without corpectomy: a multivariate analysis of an academic center cohort. Spine (Phila Pa 1976) (2014) 0.84
Multinational development of a questionnaire assessing patient satisfaction with anticoagulant treatment: the 'Perception of Anticoagulant Treatment Questionnaire' (PACT-Q). Health Qual Life Outcomes (2009) 0.83
New oral anticoagulants for the treatment of venous thromboembolism: understanding differences and similarities. Drugs (2014) 0.82
Quantifying the role of adverse events in the mortality difference between first and second-generation antipsychotics in older adults: systematic review and meta-synthesis. PLoS One (2014) 0.81
Current status of the Korean venous thromboembolism registry. Yonsei Med J (2011) 0.81
Fluctuation of serum sodium and its impact on short and long-term mortality following acute pulmonary embolism. PLoS One (2013) 0.80
Venous and arterial thrombotic risks with thalidomide: evidence and practical guidance. Ther Adv Drug Saf (2012) 0.80
Venous thromboembolism prophylaxis for hospitalized medical patients, current status and strategies to improve. Ann Thorac Med (2010) 0.80
Venous thromboembolism in nursing home residents: role of selected risk factors. J Am Geriatr Soc (2012) 0.80
Risk of venous thromboembolism in patients with idiopathic inflammatory myositis: a systematic review and meta-analysis. Rheumatol Int (2014) 0.80
Risk factors for venous thromboembolism after acute trauma: A population-based case-cohort study. Thromb Res (2016) 0.79
Increased risk of deep vein thrombosis and pulmonary thromboembolism in patients with organophosphate intoxication: a nationwide prospective cohort study. Medicine (Baltimore) (2015) 0.79
Retrievable inferior vena cava filters can be placed and removed with a high degree of success: Initial experience. Catheter Cardiovasc Interv (2015) 0.79
Venous thromboembolism in urologic surgery: prophylaxis, diagnosis, and treatment. Rev Urol (2010) 0.79
Right atrial to left atrial area ratio on early echocardiography predicts long-term survival after acute pulmonary embolism. Cardiovasc Ultrasound (2013) 0.78
Treatment of venous thromboembolism - effects of different therapeutic strategies on bleeding and recurrence rates and considerations for future anticoagulant management. Thromb J (2012) 0.78
Current and emerging strategies in the management of venous thromboembolism: benefit-risk assessment of dabigatran. Vasc Health Risk Manag (2015) 0.78
Risk of venous thromboembolism in patients nursed at home or in long-term care residential facilities. Int J Vasc Med (2011) 0.78
Bemiparin versus enoxaparin as thromboprophylaxis following vaginal and abdominal deliveries: a prospective clinical trial. BMC Pregnancy Childbirth (2015) 0.78
Serum uric acid, gout, and venous thromboembolism: The atherosclerosis risk in communities study. Thromb Res (2016) 0.77
Risk factors for incident venous thromboembolism in active cancer patients: A population based case-control study. Thromb Res (2016) 0.77
Von Willebrand factor is reversibly decreased during torpor in 13-lined ground squirrels. J Comp Physiol B (2016) 0.77
New oral antithrombotics: focus on dabigatran, an oral, reversible direct thrombin inhibitor for the prevention and treatment of venous and arterial thromboembolic disorders. Vasc Health Risk Manag (2012) 0.76
Value of venous color flow duplex scan as initial screening test for geriatric inpatients with clinically suspected pulmonary embolism. Vasc Health Risk Manag (2011) 0.76
A diagnostic strategy for pulmonary embolism based on standardised pretest probability and perfusion lung scanning: a management study. Eur J Nucl Med Mol Imaging (2003) 0.75
Improving Awareness and Outcomes Related to Venous Thromboembolism. JAMA (2015) 0.75
Deep Vein Thrombosis and Pulmonary Embolism in Liver Transplant Patients: Risks and Prevention. Transplant Direct (2016) 0.75
Long-term survival after venous thromboembolism: a retrospective selected cohort study among young women. Haematologica (2010) 0.75
Improving venous thromboembolism (VTE) prophylaxis in acute urological admissions during out of hours through the introduction of a urological admission proforma. BMJ Qual Improv Rep (2015) 0.75
Women's values and preferences for thromboprophylaxis during pregnancy: a comparison of direct-choice and decision analysis using patient specific utilities. Thromb Res (2015) 0.75
Pulmonary Embolism with Abdominal Pain and ST Elevation: A Case Report. Iran J Med Sci (2014) 0.75
Acute severe ulcerative colitis: from pathophysiology to clinical management. Nat Rev Gastroenterol Hepatol (2016) 0.75
Rheolytic Thrombectomy with or without Adjunctive Indwelling Pharmacolysis in Patients Presenting with Acute Pulmonary Embolism Presenting with Right Heart Strain and/or Pulseless Electrical Activity. Thrombosis (2011) 0.75
Fibrinogen metabolism in patients with spinal cord injury. J Spinal Cord Med (2006) 0.75
Bleeding risk with systemic thrombolytic therapy for pulmonary embolism: scope of the problem. Ther Adv Drug Saf (2015) 0.75
Family history of venous thromboembolism and mortality after venous thromboembolism: a Swedish population-based cohort study. J Thromb Thrombolysis (2016) 0.75
Population Pharmacokinetic and Pharmacodynamic Modeling Analysis of GCC-4401C, a Novel Direct Factor Xa Inhibitor, in Healthy Volunteers. CPT Pharmacometrics Syst Pharmacol (2016) 0.75
Pathogenesis of Thromboembolism and Endovascular Management. Thrombosis (2017) 0.75
Venous thromboembolism in Croatia - Croatian Cooperative Group for Hematologic Diseases (CROHEM) study. Croat Med J (2015) 0.75
Impact of catheter fragmentation followed by local intrapulmonary thrombolysis in acute high risk pulmonary embolism as primary therapy. Indian Heart J (2014) 0.75
Management of cancer-associated venous thrombosis. Vasc Health Risk Manag (2006) 0.75
Evaluation of the Management of Acute Venous Thromboembolism and Its Outcomes: One Institution's Experience. P T (2008) 0.75
Benefits of novel oral anticoagulant agents for thromboprophylaxis after total hip or knee arthroplasty. Am Health Drug Benefits (2012) 0.75
Predicting of Venous Thromboembolism for Patients Undergoing Gynecological Surgery. Medicine (Baltimore) (2015) 0.75
Prognosis of patients with suspected pulmonary embolism in Buenos Aires: a prospective cohort study. BMC Pulm Med (2014) 0.75
Risk of Pulmonary Embolism After Cerebral Venous Thrombosis. Stroke (2017) 0.75
Recent advances in the treatment of venous thromboembolism in the era of the direct oral anticoagulants. F1000Res (2017) 0.75
Venous thromboembolism after nephrectomy: incidence, timing and associated risk factors from a national multi-institutional database. World J Urol (2017) 0.75
Effect of near-universal hospitalization-based prophylaxis on annual number of venous thromboembolism events in the US. Blood (2017) 0.75
Unruptured intracranial aneurysms: natural history, clinical outcome, and risks of surgical and endovascular treatment. Lancet (2003) 11.91
The diagnosis of osteoporosis. J Bone Miner Res (1994) 10.90
Trends in the incidence of deep vein thrombosis and pulmonary embolism: a 25-year population-based study. Arch Intern Med (1998) 9.43
Risk of connective-tissue diseases and other disorders after breast implantation. N Engl J Med (1994) 9.25
Hip fractures in the elderly: a world-wide projection. Osteoporos Int (1992) 9.08
Prevalence and clinical spectrum of gastroesophageal reflux: a population-based study in Olmsted County, Minnesota. Gastroenterology (1997) 8.51
Involutional osteoporosis. N Engl J Med (1986) 8.20
Risk factors for deep vein thrombosis and pulmonary embolism: a population-based case-control study. Arch Intern Med (2000) 7.62
Psychotropic drug use and the risk of hip fracture. N Engl J Med (1987) 7.53
The use of clinical risk factors enhances the performance of BMD in the prediction of hip and osteoporotic fractures in men and women. Osteoporos Int (2007) 6.44
The worldwide problem of osteoporosis: insights afforded by epidemiology. Bone (1995) 5.76
Body mass index as a predictor of fracture risk: a meta-analysis. Osteoporos Int (2005) 5.54
Effect of fluoride treatment on the fracture rate in postmenopausal women with osteoporosis. N Engl J Med (1990) 5.49
Population-based study of herpes zoster and its sequelae. Medicine (Baltimore) (1982) 5.29
A community-based study of the epidemiology of asthma. Incidence rates, 1964-1983. Am Rev Respir Dis (1992) 5.22
Mortality following inpatient addictions treatment. Role of tobacco use in a community-based cohort. JAMA (1996) 5.17
A meta-analysis of previous fracture and subsequent fracture risk. Bone (2004) 4.92
Dyspepsia and dyspepsia subgroups: a population-based study. Gastroenterology (1992) 4.84
Incidence of clinically diagnosed vertebral fractures: a population-based study in Rochester, Minnesota, 1985-1989. J Bone Miner Res (1992) 4.75
Medical expenditures for the treatment of osteoporotic fractures in the United States in 1995: report from the National Osteoporosis Foundation. J Bone Miner Res (1997) 4.74
Population-based study of survival after osteoporotic fractures. Am J Epidemiol (1993) 4.71
Crohn's disease in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gastroenterology (1998) 4.52
Increased risk of cognitive impairment or dementia in women who underwent oophorectomy before menopause. Neurology (2007) 4.28
Relationship of serum sex steroid levels and bone turnover markers with bone mineral density in men and women: a key role for bioavailable estrogen. J Clin Endocrinol Metab (1998) 4.28
A unitary model for involutional osteoporosis: estrogen deficiency causes both type I and type II osteoporosis in postmenopausal women and contributes to bone loss in aging men. J Bone Miner Res (1998) 4.24
Treatment of postmenopausal osteoporosis with transdermal estrogen. Ann Intern Med (1992) 4.19
The prevalence by staged severity of various types of diabetic neuropathy, retinopathy, and nephropathy in a population-based cohort: the Rochester Diabetic Neuropathy Study. Neurology (1993) 4.18
Surgical management of Meckel's diverticulum. An epidemiologic, population-based study. Ann Surg (1994) 4.16
Stroke incidence, prevalence, and survival: secular trends in Rochester, Minnesota, through 1989. Stroke (1996) 4.13
Potential effect of authorization bias on medical record research. Mayo Clin Proc (1999) 4.01
Epidemiology of colonic symptoms and the irritable bowel syndrome. Gastroenterology (1991) 3.90
The prevention and treatment of osteoporosis. N Engl J Med (1992) 3.90
Effect of the fluoride/calcium regimen on vertebral fracture occurrence in postmenopausal osteoporosis. Comparison with conventional therapy. N Engl J Med (1982) 3.77
Lymphoid neogenesis in rheumatoid synovitis. J Immunol (2001) 3.63
The epidemiology of psoriatic arthritis in Olmsted County, Minnesota, USA, 1982-1991. J Rheumatol (2000) 3.62
Differential changes in bone mineral density of the appendicular and axial skeleton with aging: relationship to spinal osteoporosis. J Clin Invest (1981) 3.60
Yield of laboratory tests for case-finding in the ambulatory general medical examination. Am J Med (1996) 3.42
Carpal tunnel syndrome in Rochester, Minnesota, 1961 to 1980. Neurology (1988) 3.40
Thoracic aortic aneurysms: a population-based study. Surgery (1982) 3.36
Assessment of functional gastrointestinal disease: the bowel disease questionnaire. Mayo Clin Proc (1990) 3.34
The probability of malignancy in solitary pulmonary nodules. Application to small radiologically indeterminate nodules. Arch Intern Med (1997) 3.31
Epidemiology of vertebral fractures in women. Am J Epidemiol (1989) 3.27
Perturbation of the T-cell repertoire in patients with unstable angina. Circulation (1999) 3.20
The epidemiology of rheumatoid arthritis in Rochester, Minnesota: a study of incidence, prevalence, and mortality. Am J Epidemiol (1980) 3.19
Smoking and fracture risk: a meta-analysis. Osteoporos Int (2004) 3.08
Epidemiology of cervical radiculopathy. A population-based study from Rochester, Minnesota, 1976 through 1990. Brain (1994) 3.07
Incidence of spontaneous pneumothorax in Olmsted County, Minnesota: 1950 to 1974. Am Rev Respir Dis (1979) 3.06
T cell homeostasis in patients with rheumatoid arthritis. Proc Natl Acad Sci U S A (2000) 3.06
Secular trends in the incidence of hip and other osteoporotic fractures. Osteoporos Int (2011) 3.04
Plasma cell labeling index and beta 2-microglobulin predict survival independent of thymidine kinase and C-reactive protein in multiple myeloma. Blood (1993) 2.98
Trends in the incidence and mortality of systemic lupus erythematosus, 1950-1992. Arthritis Rheum (1999) 2.98
Epidemiology of anaphylaxis in Olmsted County: A population-based study. J Allergy Clin Immunol (1999) 2.95
Relative contributions of testosterone and estrogen in regulating bone resorption and formation in normal elderly men. J Clin Invest (2000) 2.94
Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. A population-based study in Olmsted County, Minnesota, 1975-1984. Circulation (1989) 2.94
Epidemiology of fractures of the proximal femur in Rochester, Minnesota. Clin Orthop Relat Res (1981) 2.93
Standardized problem list generation, utilizing the Mayo canonical vocabulary embedded within the Unified Medical Language System. Proc AMIA Annu Fall Symp (1997) 2.93
Changes in bone mineral density of the proximal femur and spine with aging. Differences between the postmenopausal and senile osteoporosis syndromes. J Clin Invest (1982) 2.92
Risk factors for irritable bowel syndrome: role of analgesics and food sensitivities. Am J Gastroenterol (2000) 2.89
Ulcerative colitis in Olmsted County, Minnesota, 1940-1993: incidence, prevalence, and survival. Gut (2000) 2.86
Fractures after rheumatoid arthritis. A population-based study. Arthritis Rheum (1984) 2.85
Fracture incidence in Olmsted County, Minnesota: comparison of urban with rural rates and changes in urban rates over time. Osteoporos Int (1999) 2.83
Incidence and natural history of primary systemic amyloidosis in Olmsted County, Minnesota, 1950 through 1989. Blood (1992) 2.81
Prevalence of potential risk factors for stroke assessed by transesophageal echocardiography and carotid ultrasonography: the SPARC study. Stroke Prevention: Assessment of Risk in a Community. Mayo Clin Proc (1999) 2.80
Relapsing polychondritis. Survival and predictive role of early disease manifestations. Ann Intern Med (1986) 2.80
Epidemiologic features of humeral fractures. Clin Orthop Relat Res (1982) 2.79
Renal stone epidemiology: a 25-year study in Rochester, Minnesota. Kidney Int (1979) 2.79
Ischemic stroke subtypes : a population-based study of functional outcome, survival, and recurrence. Stroke (2000) 2.78
Value of immunological markers in predicting responsiveness to influenza vaccination in elderly individuals. J Virol (2001) 2.78
Predictors of recurrence after deep vein thrombosis and pulmonary embolism: a population-based cohort study. Arch Intern Med (2000) 2.77
Risk factors associated with symptoms of gastroesophageal reflux. Am J Med (1999) 2.75
Implications of absolute fracture risk assessment for osteoporosis practice guidelines in the USA. Osteoporos Int (2008) 2.74
Cost-effective osteoporosis treatment thresholds: the United States perspective. Osteoporos Int (2008) 2.72
Frequency of atrial septal aneurysms in patients with cerebral ischemic events. Circulation (1999) 2.71
A randomized trial of plasma exchange in acute central nervous system inflammatory demyelinating disease. Ann Neurol (1999) 2.69
Natural history of erythromelalgia: presentation and outcome in 168 patients. Arch Dermatol (2000) 2.68
Intercessory prayer and cardiovascular disease progression in a coronary care unit population: a randomized controlled trial. Mayo Clin Proc (2001) 2.61
Long-term fracture prediction by bone mineral assessed at different skeletal sites. J Bone Miner Res (1993) 2.59
Indications for use of hepatitis B vaccine, based on cost-effectiveness analysis. N Engl J Med (1982) 2.58
Ischemic stroke subtypes: a population-based study of incidence and risk factors. Stroke (1999) 2.56
Bleeding and thromboembolism during anticoagulant therapy: a population-based study in Rochester, Minnesota. Mayo Clin Proc (1995) 2.55